Iron overload in patients undergoing hematopoietic stem cell transplantation.
about
Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation.Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT.Review of therapeutic options and the management of patients with myelodysplastic syndromes.Safety and efficacy of deferasirox in the management of transfusion-dependent patients with myelodysplastic syndrome and aplastic anaemia: a perspective review.Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes.Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience.Comparing the ratio of mean red blood cell transfusion episode rate of 1 unit versus 2 units in hematopoietic stem cell transplant patients.Intracellular iron overload leading to DNA damage of lymphocytes and immune dysfunction in thalassemia major patients.Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT).Impact of labile plasma iron and iron chelation on the viability of cultured mononuclear cells from patients undergoing autologous hematopoietic stem cell transplantation.Iron toxicity in hematopoietic stem cell transplantation: Strike while the iron is labile.Clinical significance of pre- and 1-year post-transplant serum ferritin among adult transplant recipients.A higher prevalence of hematologic malignancies in patients with thalassemia: Background and culprits.Osteopontin deletion drives hematopoietic stem cell mobilization to the liver and increases hepatic iron contributing to alcoholic liver disease.
P2860
Q36439892-55C6599B-84A2-465F-BBD7-8915B575B4EBQ37389675-E24765FD-AA18-4EBC-B945-51E33DE1AD23Q38095121-EA773E50-8B89-49C1-9C9B-6CE6B5B0C9A7Q38101043-4B822DC7-E6BB-4E07-A922-856C7DF60792Q38196963-8D184048-438A-45D5-AEEE-A17BA6D180BFQ38406744-A3A0C62E-80F7-4952-9C25-3F51B4BDD3D5Q38915707-203C8B49-5E9D-4DCC-98BC-67BD19806B87Q40090410-CB6E43F2-9382-4220-8E38-BF09641BC1B0Q40171404-D8CA5B04-7E59-4DA0-A72D-DF722F113203Q40973151-8BE80F2A-FD77-4163-A195-7346324EFBBCQ43554948-DB1079C9-0161-4BC8-BB69-4E2B456F0C5FQ45947630-41AA3442-E86D-43F0-A825-571A3BB771C1Q48239911-B5BE2D5C-B774-495B-B67F-585B488CDCC9Q52699057-1F537DE9-99FD-4567-99DF-001AEC8A908F
P2860
Iron overload in patients undergoing hematopoietic stem cell transplantation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Iron overload in patients undergoing hematopoietic stem cell transplantation.
@en
type
label
Iron overload in patients undergoing hematopoietic stem cell transplantation.
@en
prefLabel
Iron overload in patients undergoing hematopoietic stem cell transplantation.
@en
P2860
P356
P1476
Iron overload in patients undergoing hematopoietic stem cell transplantation.
@en
P2093
Vinod Pullarkat
P2860
P304
P356
10.1155/2010/345756
P577
2010-09-08T00:00:00Z